CMB305

· Immune Design (a Merck subsidiary)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CMB305, covering 2020-05-14 to 2020-05-14. Get the full timeline:

Most recent: Clinical Trial Update: Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) [Phase 2]

See pricing